The Centre has approved Biological E’s Corbevax as a precaution dose after completion of six months from the date of administration of the second dose of either Covaxin or Covishield vaccines for the population above 18 years, said Union health secretary Rajesh Bhushan. The latest move by the Centre, amid rising Covid-19 cases in many states, is significant as this is for the first time that a booster dose that is different from the one used for primary vaccination against Covid-19 has been allowed in the country”. News agency PTI earlier reported that the Union health ministry took the decision after the recommendations made recently by the COVID-19 Working Group of the National Technical Advisory Group on Immunization (NTAGI). Corbevax, India’s first indigenously developed RBD protein subunit vaccine, is currently being used to inoculate children in the age group of 12 to 14 years under the immunization programme. View More….